Trial Profile
A Phase I Study of Pemetrexed, Carboplatin, and Radiation Therapy in Locally Advanced Non-Squamous-Cell, Non-Small-Cell Lung Cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 12 Jul 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 10 Jul 2017 Status changed from recruiting to discontinued.
- 24 Jul 2014 New trial record